Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
dyslipidemias/oksendamine
Link salvestatakse lõikelauale
14 tulemused
Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Study Setting:
The present study is a single blinded placebo-controlled randomized clinical trial, in which target individuals were obese females (BMI≥30 kg/m2), within the age of 20-60 years, attending the Obesity research and therapy unit of Al-Kindy College of Medicine, University of Baghdad
Osmotic Agent Use in Middle Cerebral Artery Stroke
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
MCA Stroke is a fatal disease with reported mortality of about 80% of cases without decompressive craniectomy. Osmotic agents like hypertonic saline & mannitol have been used in acute MCA stroke cases without no evidence of benefit. Its use in elevated ICP can be only justified as a bridge to the
The Effect of Health Education Program on Level of Awareness for Stroke Among Population
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The aim of the current study is to increase level of the awareness regarding risk factors and warning signs of stroke among population at risk who attending the primary health care center at Jeddah city in Saudi Arabia.
The primary objective of this study is to assess the effectiveness of the health
Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Research design This study is a double blind randomized clinical trial to determine differences in wave amplitude P50 and N95 on pattern ERG examination, visual field defects (LP) with Humphrey HFA (Humphrey Field Analyzer) II-i 750, 24-2 threshold and ganglion cell thickness with OCT CirrusTM
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND:
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive age women with a prevalence as high as 15% using Rotterdam diagnostic criteria.1 PCOS is a heterogeneous clinical disorder characterized primarily by chronic anovulation and hyperandrogenism.2 A
Bosutinib in Elderly Chronic Myeloid Leukemia
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Bosutinib is a potent tyrosine kinase inhibitor (TKI) active at nM concentration on BCR-ABL1 and most BCR-ABL1 mutations. Bosutinib has been approved by the FDA and the EMA for the treatment of patients with Ph+/BCR-ABL1+ chronic myeloid leukemia who fail treatment with other TKIs, first or second
Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
4. STUDY DESIGN 4.1. Endpoints Main endpoint Eradication of infection "by intention to treat". Secondary endpoints Eradication of infection "per protocol". Adherence to treatment. Medication side effects.
Clinical and demographic variables:
1) Age; 2) Sex; 3) Smoking habit; 4) Comorbidity (diabetes
Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background and Significance
Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical-radiological syndrome. It was first described by Hinchey et al. in 1996. It is characterized by a variable combination of headaches, seizures, altered mental status, visual impairment, nausea, vomiting and
Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Diabetes mellitus is a complex heterogeneous group of metabolic conditions characterized by increased levels of blood glucose due to impairment in insulin action and/or insulin secretion. Diabetes is a condition primarily defined by the level of hyperglycemia giving rise to risk of microvascular
Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Patients >18 years of age who were admitted to the Cardiovascular Intensive Care Unit of the Cardiology Hospital, National Medical Center, Century XXI (Mexico City) and diagnosed with ST segment elevation Acute Coronary Syndrome (ACS) and hyperfibrinogenemia within 72 h of symptom onset were
Statin Distribution
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The ultimate goal of this proposed investigation is to establish the role of genetic variation and development in key transporters on the dose-exposure relationship of two commonly used statin drugs in children. This study is the first step in a series of investigations aimed at determining the
Metformin in Overweight Type 2 Diabetes Mellitus
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
From 1st February 2006 till 31st December 2008, 800 cases of diabetes mellitus who attended the diabetes clinic constituted the subjects for the present study. Majority of the subjects were from the state of Uttar Pradesh (UP). UP is the fifth largest state of India, Lucknow being the capital of UP.
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
BACKGROUND: In recent years, the need to achieve increasingly ambitious therapeutic goals for dyslipidemias has prompted the search for more potent pharmacological agents to lower circulating atherogenic lipoprotein concentrations and enhance reverse cholesterol transport (RCT). While
Comparison of Immunosuppression Protocols After LTx in Children
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A: Study group
FK506-MMF.
Immunosupression protocol:
Metylprednisolon 10 mg/kg intraoperatively i.v.
FK506 Day 0 or 1 oraly (0,15 mg/kg/D in two doses).
MMF max. dosage 30 mg/kg/D p.o. day 0 through day 90 according to patient condition and therapeutic MMF blood
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
